{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:03:20Z","timestamp":1791461000544,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473553"],"award-info":[{"award-number":["82473553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273556"],"award-info":[{"award-number":["82273556"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Youth Foundation of Sichuan Province of China","award":["2025NSFJQ0070"],"award-info":[{"award-number":["2025NSFJQ0070"]}]},{"name":"Natural Science Foundation of Sichuan Province of China","award":["2025ZNSFSC0666"],"award-info":[{"award-number":["2025ZNSFSC0666"]}]},{"name":"Natural Science Foundation of Sichuan Province of China","award":["2025ZNSFSC1525"],"award-info":[{"award-number":["2025ZNSFSC1525"]}]},{"name":"Natural Science Foundation of Sichuan Province of China","award":["2025ZNSFSC1547"],"award-info":[{"award-number":["2025ZNSFSC1547"]}]},{"name":"Natural Science Foundation of Sichuan Province of China","award":["2026NSFSC1616"],"award-info":[{"award-number":["2026NSFSC1616"]}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["2022SCUH0033"],"award-info":[{"award-number":["2022SCUH0033"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["YGJC004"],"award-info":[{"award-number":["YGJC004"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["2025-395"],"award-info":[{"award-number":["2025-395"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["2023HXFH004"],"award-info":[{"award-number":["2023HXFH004"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21060."],"award-info":[{"award-number":["ZYJC21060."]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whilst \u03b2-blockers have revolutionized the management of complicated infantile hemangiomas (IHs), ulceration remains a highly painful and clinically challenging complication. Ulcerated IHs may lead to pain, bleeding, secondary infection, feeding or diaper-care difficulties, functional impairment, and permanent scarring. Early recognition and integrated management are therefore essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>This narrative review searched PubMed, Embase, and Cochrane Library databases from inception to June 2026 for studies concerning ulcerated IH. The search was restricted to publications written in English; relevant evidence was synthesized in a narrative fashion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ulceration is more likely to occur in rapidly proliferating, large, superficial, mixed, segmental, or partially segmental IHs. This is particularly so for those involving the lips, neck, diaper area, perineal or anogenital region, and skin folds. Early white discoloration is an important warning sign of impending ulceration. Current evidence suggests that ulceration should not be regarded merely as a surface wound but as a dynamic manifestation of active hemangioma proliferation, local tissue vulnerability, environmental barrier disruption, inflammation, and delayed wound repair. Oral propranolol remains the main systemic treatment, whereas wound care, pain control, infection surveillance, topical \u03b2-blockers, pulsed dye laser treatment, and individualized multimodal therapy may be needed according to ulcer severity and the anatomical site involved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the \u03b2-blocker era, ulcerated IH remains an important clinical problem requiring early risk stratification and integrated lesion-directed and wound-directed management. Future prospective multicenter and mechanistic studies are needed to standardize assessments of severity, refine risk-stratified treatment algorithms, and improve long-term functional and cosmetic outcomes for infants with ulcerated IHs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12519-026-01101-x","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:47:50Z","timestamp":1791460070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ulcerated infantile hemangioma in the \u03b2-blocker era: recent advances"],"prefix":"10.1007","author":[{"given":"Kai-Zhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-9660","authenticated-orcid":false,"given":"Yi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"1101_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jaad.2021.08.019","volume":"85","author":"AI Rodr\u00edguez Bandera","year":"2021","unstructured":"Rodr\u00edguez Bandera AI, Sebaratnam DF, Wargon O, Wong LF. Infantile hemangioma. Part 1: epidemiology, pathogenesis, clinical presentation and assessment. J Am Acad Dermatol. 2021;85:1379\u201392. https:\/\/doi.org\/10.1016\/j.jaad.2021.08.019.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390:85\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(16)00645-0.","journal-title":"Lancet"},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaad.2015.08.024","volume":"74","author":"KR Anderson","year":"2016","unstructured":"Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol. 2016;74:120\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2015.08.024.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/pde.13187","volume":"34","author":"A Seiffert","year":"2017","unstructured":"Seiffert A, Schneider M, Roessler J, Larisch K, Pfeiffer D. Incidence, treatment patterns, and health care costs of infantile hemangioma: results of a retrospective German database analysis. Pediatr Dermatol. 2017;34:450\u20137. https:\/\/doi.org\/10.1111\/pde.13187.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1525-1470.2011.01568.x","volume":"28","author":"P Dickison","year":"2011","unstructured":"Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011;28:663\u20139. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01568.x.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.12804","volume":"170","author":"A Munden","year":"2014","unstructured":"Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170:907\u201313. https:\/\/doi.org\/10.1111\/bjd.12804.","journal-title":"Br J Dermatol"},{"key":"1101_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jaad.2021.08.020","volume":"85","author":"DF Sebaratnam","year":"2021","unstructured":"Sebaratnam DF, Rodr\u00edguez Bandera AL, Wong LF, Wargon O. Infantile hemangioma. Part 2: management. J Am Acad Dermatol. 2021;85:1395\u2013404. https:\/\/doi.org\/10.1016\/j.jaad.2021.08.020.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/pde.70077","volume":"43","author":"N Schiraldi","year":"2026","unstructured":"Schiraldi N, Rookwood R, Salman M, Heibel H, Gittler J. Late-ulcerating infantile hemangioma responsive to propranolol: a case and literature review. Pediatr Dermatol. 2026;43:425\u20139. https:\/\/doi.org\/10.1111\/pde.70077.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jpeds.2007.04.055","volume":"151","author":"SL Chamlin","year":"2007","unstructured":"Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007;151:684\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2007.04.055.","journal-title":"J Pediatr"},{"key":"1101_CR10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3475","volume":"143","author":"DP Krowchuk","year":"2019","unstructured":"Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143:e20183475. https:\/\/doi.org\/10.1542\/peds.2018-3475.","journal-title":"Pediatrics"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","volume":"136","author":"DH Darrow","year":"2015","unstructured":"Darrow DH, Greene AK, Mancini AJ, Nopper AJ, Section on Dermatology, Section on Otolaryngology\u2013Head and Neck Surgery, et al. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136:e1060\u2013104. https:\/\/doi.org\/10.1542\/peds.2015-2485.","journal-title":"Pediatrics"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Ta\u00efeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649\u201351. https:\/\/doi.org\/10.1056\/NEJMc0708819.","journal-title":"N Engl J Med"},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaoto.2021.0454","volume":"147","author":"Y Ji","year":"2021","unstructured":"Ji Y, Chen S, Yang K, Zhang X, Zhou J, Li L, et al. Efficacy and safety of propranolol vs. atenolol in infants with problematic infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2021;147:599\u2013607. https:\/\/doi.org\/10.1001\/jamaoto.2021.0454.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1101_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01321-2","volume":"7","author":"Y Ji","year":"2017","unstructured":"Ji Y, Chen S, Xiang B, Yang Y, Qiu L. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study. Sci Rep. 2017;7:1503. https:\/\/doi.org\/10.1038\/s41598-017-01321-2.","journal-title":"Sci Rep"},{"key":"1101_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1404710.","journal-title":"N Engl J Med"},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","volume":"174","author":"PH Hoeger","year":"2015","unstructured":"Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Ciofi Degli Atti M, et al. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174:855\u201365. https:\/\/doi.org\/10.1007\/s00431-015-2570-0.","journal-title":"Eur J Pediatr"},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128\u201340. https:\/\/doi.org\/10.1542\/peds.2012-1691.","journal-title":"Pediatrics"},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjd.13388","volume":"172","author":"Y Ji","year":"2015","unstructured":"Ji Y, Chen S, Xu C, Li L, Xiang B. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol. 2015;172:24\u201332. https:\/\/doi.org\/10.1111\/bjd.13388.","journal-title":"Br J Dermatol"},{"key":"1101_CR19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3866","volume":"142","author":"E Baselga","year":"2018","unstructured":"Baselga E, Dembowska-Baginska B, Przewratil P, Gonz\u00e1lez-Ense\u00f1at MA, Wyrzykowski D, Torrelo A, et al. Efficacy of propranolol between 6 and 12 months of age in high-risk infantile hemangioma. Pediatrics. 2018;142:e20173866. https:\/\/doi.org\/10.1542\/peds.2017-3866.","journal-title":"Pediatrics"},{"key":"1101_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jaad.2021.04.055","volume":"86","author":"Y Ji","year":"2022","unstructured":"Ji Y, Yang K, Zhou J, Zhang X, Xiang B, Jiang X, et al. Propranolol for the treatment of ulcerated infantile hemangiomas: a prospective study. J Am Acad Dermatol. 2022;86:1149\u201351. https:\/\/doi.org\/10.1016\/j.jaad.2021.04.055.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/00006534-199704001-00014","volume":"99","author":"BM Achauer","year":"1997","unstructured":"Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99:1301\u20138. https:\/\/doi.org\/10.1097\/00006534-199704001-00014.","journal-title":"Plast Reconstr Surg"},{"key":"1101_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1684\/ejd.2008.0576","volume":"19","author":"DJ Hermans","year":"2009","unstructured":"Hermans DJ, Boezeman JB, Van de Kerkhof PC, Rieu PN, Van der Vleuten CJ. Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases. Eur J Dermatol. 2009;19:152\u20136. https:\/\/doi.org\/10.1684\/ejd.2008.0576.","journal-title":"Eur J Dermatol"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1742-481X.2008.00562.x","volume":"6","author":"A Pandey","year":"2009","unstructured":"Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gopal SC, Gupta DK. Conservative management of ulcerated haemangioma-twenty years experience. Int Wound J. 2009;6:59\u201362. https:\/\/doi.org\/10.1111\/j.1742-481X.2008.00562.x.","journal-title":"Int Wound J"},{"key":"1101_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archderm.138.12.1567","volume":"138","author":"KG Chiller","year":"2002","unstructured":"Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138:1567\u201376. https:\/\/doi.org\/10.1001\/archderm.138.12.1567.","journal-title":"Arch Dermatol"},{"key":"1101_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaad.2022.10.047","volume":"88","author":"E Fern\u00e1ndez Faith","year":"2023","unstructured":"Fern\u00e1ndez Faith E, Shah SD, Braun M, Pope E, Lara-Corrales I, et al. Incidence and clinical factors associated with ulceration in infantile hemangiomas. J Am Acad Dermatol. 2023;88:414\u201320. https:\/\/doi.org\/10.1016\/j.jaad.2022.10.047.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2026.06.005","author":"K Zhang","year":"2026","unstructured":"Zhang K, Qiu T, Gong X, Zhou J, Yang L, Han Y, et al. Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: a retrospective study. J Am Acad Dermatol. 2026. https:\/\/doi.org\/10.1016\/j.jaad.2026.06.005.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamadermatol.2021.0469","volume":"157","author":"E Fern\u00e1ndez Faith","year":"2021","unstructured":"Fern\u00e1ndez Faith E, Shah S, Witman PM, Harfmann K, Bradley F, Blei F, et al. Clinical features, prognostic factors, and treatment interventions for ulceration in patients with infantile hemangioma. JAMA Dermatol. 2021;157:566\u201372. https:\/\/doi.org\/10.1001\/jamadermatol.2021.0469.","journal-title":"JAMA Dermatol"},{"key":"1101_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ad.2011.07.018","volume":"103","author":"A Lanoel","year":"2012","unstructured":"Lanoel A, Tosi V, Bocian M, Lubieniecki F, Poblete SB, Garc\u00eda HO, et al. Perianal ulcers on a segmental hemangioma with minimal or arrested growth. Actas Dermosifiliogr. 2012;103:820\u20133. https:\/\/doi.org\/10.1016\/j.ad.2011.07.018.","journal-title":"Actas Dermosifiliogr"},{"key":"1101_CR29","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/j.1365-2133.2007.07771.x","volume":"156","author":"HT Shin","year":"2007","unstructured":"Shin HT, Orlow SJ, Chang MW. Ulcerated haemangioma of infancy: a retrospective review of 47 patients. Br J Dermatol. 2007;156:1050\u20132. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07771.x.","journal-title":"Br J Dermatol"},{"key":"1101_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jaad.2023.06.049","volume":"89","author":"JD Arnold","year":"2023","unstructured":"Arnold JD, Yoon S, Shah N, Byrne M, Kieswetter L, Sibbald C, et al. Characteristics and complications of anogenital infantile hemangiomas: a multicenter retrospective analysis. J Am Acad Dermatol. 2023;89:1015\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2023.06.049.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/jdv.16331","volume":"34","author":"L Yu","year":"2020","unstructured":"Yu L, Li LL, Yan P, Deng L, Gan XL, Yao XJ, et al. Clinical characteristics of lip infantile haemangiomas and main risk factors for ulceration: an 8-year retrospective study of 69 Chinese infants. J Eur Acad Dermatol Venereol. 2020;34:2135\u20139. https:\/\/doi.org\/10.1111\/jdv.16331.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1101_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1525-1470.2012.01879.x","volume":"30","author":"D Metry","year":"2013","unstructured":"Metry D, Frieden IJ, Hess C, Siegel D, Maheshwari M, Baselga E, et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol. 2013;30:71\u201389. https:\/\/doi.org\/10.1111\/j.1525-1470.2012.01879.x.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.abd.2021.05.009","volume":"97","author":"LG Mariani","year":"2022","unstructured":"Mariani LG, Ferreira LM, Rovaris DL, Bonamigo RR, Kiszewski AE. Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae. An Bras Dermatol. 2022;97:37\u201344. https:\/\/doi.org\/10.1016\/j.abd.2021.05.009.","journal-title":"An Bras Dermatol"},{"key":"1101_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/TCRM.S291059","volume":"17","author":"T Qiu","year":"2021","unstructured":"Qiu T, Yang K, Dai S, Chen S, Ji Y. Clinical features of segmental infantile hemangioma: a prospective study. Ther Clin Risk Manag. 2021;17:119\u201325. https:\/\/doi.org\/10.2147\/TCRM.S291059.","journal-title":"Ther Clin Risk Manag"},{"key":"1101_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/apa.13460","volume":"105","author":"E Castr\u00e9n","year":"2016","unstructured":"Castr\u00e9n E, Salminen P, Gissler M, Stefanovic V, Pitk\u00e4ranta A, Klockars T. Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration. Acta Paediatr. 2016;105:940\u20135. https:\/\/doi.org\/10.1111\/apa.13460.","journal-title":"Acta Paediatr"},{"key":"1101_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202100029","volume":"43","author":"PP Yee","year":"2021","unstructured":"Yee PP, Li W. Tumor necrosis: a synergistic consequence of metabolic stress and inflammation. BioEssays. 2021;43:e2100029. https:\/\/doi.org\/10.1002\/bies.202100029.","journal-title":"BioEssays"},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/archdermatol.2010.324","volume":"146","author":"SM Maguiness","year":"2010","unstructured":"Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146:1235\u20139. https:\/\/doi.org\/10.1001\/archdermatol.2010.324.","journal-title":"Arch Dermatol"},{"key":"1101_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1525-1470.2005.00102.x","volume":"22","author":"IJ Frieden","year":"2005","unstructured":"Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, et al. Infantile hemangiomas: current knowledge future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol. 2005;22:383\u2013406. https:\/\/doi.org\/10.1111\/j.1525-1470.2005.00102.x.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/pde.12596","volume":"32","author":"AM Kutz","year":"2015","unstructured":"Kutz AM, Aranibar L, Lobos N, Wortsman X. Color Doppler ultrasound follow-up of infantile hemangiomas and peripheral vascularity in patients treated with propranolol. Pediatr Dermatol. 2015;32:468\u201375. https:\/\/doi.org\/10.1111\/pde.12596.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.718135","volume":"9","author":"GK Parapatt","year":"2021","unstructured":"Parapatt GK, Oranges T, Paolantonio G, Rav\u00e0 L, Giancristoforo S, Diociaiuti A, et al. Color Doppler evaluation of arterial resistive index in infantile hemangioma: a useful parameter to monitor the response to oral propranolol. Front Pediatr. 2021;9:718135. https:\/\/doi.org\/10.3389\/fped.2021.718135.","journal-title":"Front Pediatr"},{"key":"1101_CR41","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1067\/mjd.2001.112382","volume":"44","author":"HJ Kim","year":"2001","unstructured":"Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44:962\u201372. https:\/\/doi.org\/10.1067\/mjd.2001.112382.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1542\/peds.99.2.256","volume":"99","author":"MG Liang","year":"1997","unstructured":"Liang MG, Frieden IJ. Perineal and lip ulcerations as the presenting manifestation of hemangioma of infancy. Pediatrics. 1997;99:256\u20139. https:\/\/doi.org\/10.1542\/peds.99.2.256.","journal-title":"Pediatrics"},{"key":"1101_CR43","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1542\/peds.2006-0413","volume":"118","author":"AN Haggstrom","year":"2006","unstructured":"Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118:882\u20137. https:\/\/doi.org\/10.1542\/peds.2006-0413.","journal-title":"Pediatrics"},{"key":"1101_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3928\/00904481-20120727-08","volume":"41","author":"LC Uihlein","year":"2012","unstructured":"Uihlein LC, Liang MG, Mulliken JB. Pathogenesis of infantile hemangiomas. Pediatr Ann. 2012;41:1\u20136. https:\/\/doi.org\/10.3928\/00904481-20120727-08.","journal-title":"Pediatr Ann"},{"key":"1101_CR45","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jamaoto.2013.4773","volume":"139","author":"S Thaivalappil","year":"2013","unstructured":"Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. 2013;139:1026\u201331. https:\/\/doi.org\/10.1001\/jamaoto.2013.4773.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1101_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2337\/dci22-0043","volume":"46","author":"K McDermott","year":"2023","unstructured":"McDermott K, Fang M, Boulton A, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46:209\u201321. https:\/\/doi.org\/10.2337\/dci22-0043.","journal-title":"Diabetes Care"},{"key":"1101_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1203475418770570","volume":"22","author":"JY Wang","year":"2018","unstructured":"Wang JY, Ighani A, Ayala AP, Akita S, Lara-Corrales I, Alavi A. Medical, surgical, and wound care management of ulcerated infantile hemangiomas: a systematic review. J Cutan Med Surg. 2018;22:495\u2013504. https:\/\/doi.org\/10.1177\/1203475418770570.","journal-title":"J Cutan Med Surg"},{"key":"1101_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/pde.15444","volume":"40","author":"A Gautam","year":"2023","unstructured":"Gautam A, Frieden IJ, Shah SD, Witman PM, Harfmann K, Bradley F, et al. Clinical characteristics of infantile hemangiomas with aggressive, persistent, and destructive ulceration. Pediatr Dermatol. 2023;40:996\u20131002. https:\/\/doi.org\/10.1111\/pde.15444.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2581741","volume":"36","author":"A Chu","year":"2025","unstructured":"Chu A, Cheng J, Lam YY, Bao W, Luk D. Clinical characteristics, treatment outcomes and prognostic factors of ulcerated infantile hemangioma: 15 years of experience from a pediatric dermatology center in Hong Kong. J Dermatolog Treat. 2025;36:2581741. https:\/\/doi.org\/10.1080\/09546634.2025.2581741.","journal-title":"J Dermatolog Treat"},{"key":"1101_CR50","first-page":"1220","volume":"85","author":"S Wananukul","year":"2002","unstructured":"Wananukul S, Chatproedprai S. Ulcerated hemangiomas: clinical features and management. J Med Assoc Thai. 2002;85:1220\u20135.","journal-title":"J Med Assoc Thai"},{"key":"1101_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PRS.0000000000012186","volume":"157","author":"J Zhou","year":"2026","unstructured":"Zhou J, Zhang Z, Lan Y, Yang M, Qiu T, Yang K, et al. Long-term outcomes of oral propranolol for facial infantile hemangioma. Plast Reconstr Surg. 2026;157:142\u20139. https:\/\/doi.org\/10.1097\/PRS.0000000000012186.","journal-title":"Plast Reconstr Surg"},{"key":"1101_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archdermatol.2011.926","volume":"148","author":"AN Haggstrom","year":"2012","unstructured":"Haggstrom AN, Beaumont JL, Lai JS, Adams DM, Drolet BA, Frieden IJ, et al. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol. 2012;148:197\u2013202. https:\/\/doi.org\/10.1001\/archdermatol.2011.926.","journal-title":"Arch Dermatol"},{"key":"1101_CR53","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1365-2230.2011.04080.x","volume":"36","author":"SR Janmohamed","year":"2011","unstructured":"Janmohamed SR, de Waard-Van Der Spek FB, Madern GC, de Laat PC, Hop WC, Oranje AP. Scoring the proliferative activity of haemangioma of infancy: the haemangioma activity score (HAS). Clin Exp Dermatol. 2011;36:715\u201323. https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04080.x.","journal-title":"Clin Exp Dermatol"},{"key":"1101_CR54","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/jid.2015.18","volume":"135","author":"SL Chamlin","year":"2015","unstructured":"Chamlin SL, Mancini AJ, Lai JS, Beaumont JL, Cella D, Adams D, et al. Development and validation of a quality-of-life instrument for infantile hemangiomas. J Invest Dermatol. 2015;135:1533\u20139. https:\/\/doi.org\/10.1038\/jid.2015.18.","journal-title":"J Invest Dermatol"},{"key":"1101_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2340\/00015555-1847","volume":"95","author":"O Boccara","year":"2015","unstructured":"Boccara O, M\u00e9ni C, L\u00e9aut\u00e9-Labreze C, Bodemer C, Voisard JJ, Dufresne H, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol. 2015;95:78\u201382. https:\/\/doi.org\/10.2340\/00015555-1847.","journal-title":"Acta Derm Venereol"},{"key":"1101_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/02844310801924167","volume":"42","author":"CG Bauland","year":"2008","unstructured":"Bauland CG, Smit JM, Ketelaars R, Rieu PN, Spauwen PH. Management of haemangiomas of infancy: a retrospective analysis and a treatment protocol. Scand J Plast Reconstr Surg Hand Surg. 2008;42:86\u201391. https:\/\/doi.org\/10.1080\/02844310801924167.","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"1101_CR57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/iwj.12740","volume":"14","author":"Z Lokmic","year":"2017","unstructured":"Lokmic Z, Grainger T, Atapattu NV, Phillips RJ, Penington AJ. Wound management of ulcerated haemangioma of infancy-an audit. Int Wound J. 2017;14:967\u201372. https:\/\/doi.org\/10.1111\/iwj.12740.","journal-title":"Int Wound J"},{"key":"1101_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000018311","volume":"200","author":"AP Oranje","year":"2000","unstructured":"Oranje AP, de Waard-van der Spek FB, Devillers AC, de Laat PC, Madern GC. Treatment and pain relief of ulcerative hemangiomas with a polyurethane film. Dermatology. 2000;200:31\u20134. https:\/\/doi.org\/10.1159\/000018311.","journal-title":"Dermatology"},{"key":"1101_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01334-2","volume":"48","author":"M Pensabene","year":"2022","unstructured":"Pensabene M, Di Pace MR, Baldanza F, Grasso F, Patti M, Sergio M, et al. Quality of life improving after propranolol treatment in patients with infantile hemangiomas. Ital J Pediatr. 2022;48:140. https:\/\/doi.org\/10.1186\/s13052-022-01334-2.","journal-title":"Ital J Pediatr"},{"key":"1101_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1525-1470.2011.01679.x","volume":"29","author":"M Strand","year":"2012","unstructured":"Strand M, Smidt AC. Pain management for ulcerated infantile hemangiomas. Pediatr Dermatol. 2012;29:124\u20136. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01679.x.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR61","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jaad.2010.12.040","volume":"64","author":"M Saint-Jean","year":"2011","unstructured":"Saint-Jean M, L\u00e9aut\u00e9-Labr\u00e8ze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64:827\u201332. https:\/\/doi.org\/10.1016\/j.jaad.2010.12.040.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10006-015-0528-z","volume":"20","author":"P Tiwari","year":"2016","unstructured":"Tiwari P, Pandey V, Gangopadhyay AN, Sharma SP, Gupta DK. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study. J Oral Maxillofac Surg. 2016;20:73\u20137. https:\/\/doi.org\/10.1007\/s10006-015-0528-z.","journal-title":"J Oral Maxillofac Surg"},{"key":"1101_CR63","doi-asserted-by":"publisher","DOI":"10.5070\/D3195018298","volume":"19","author":"S Al Dosari","year":"2013","unstructured":"Al Dosari S, Riad H. Ulcerated nasal infantile haemangioma treated by oral propranolol. Dermatol Online J. 2013;19:18298. https:\/\/doi.org\/10.5070\/D3195018298.","journal-title":"Dermatol Online J"},{"key":"1101_CR64","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ad.2011.02.009(inSpanish)","volume":"102","author":"J Bernabeu-Wittel","year":"2011","unstructured":"Bernabeu-Wittel J, Pereyra-Rodr\u00edguez JJ, Mantrana-Bermejo ME, Fern\u00e1ndez-Pineda I, de Agust\u00edn JC, Conejo-Mir J. Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients. Actas Dermosifiliogr. 2011;102:510\u20136. https:\/\/doi.org\/10.1016\/j.ad.2011.02.009(inSpanish).","journal-title":"Actas Dermosifiliogr"},{"key":"1101_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjae114","volume":"2024","author":"A Shah","year":"2024","unstructured":"Shah A, Tollefson M, Ahn ES, Gibreel W, Polites S. Successful treatment of ulcerated hemangioma with diversion colostomy in a neonate with LUMBAR syndrome. J Surg Case Rep. 2024;2024:rjae114. https:\/\/doi.org\/10.1093\/jscr\/rjae114.","journal-title":"J Surg Case Rep"},{"key":"1101_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1468-3083.2010.03603.x","volume":"24","author":"M Naouri","year":"2010","unstructured":"Naouri M, Schill T, Maruani A, Bross F, Lorette G, Rossler J. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol. 2010;24:1109\u201312. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03603.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1101_CR67","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jpedsurg.2011.01.012","volume":"46","author":"L Kim","year":"2011","unstructured":"Kim L, Hogeling M, Wargon O, Jiwane A, Adams S. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg. 2011;46:759\u201363. https:\/\/doi.org\/10.1016\/j.jpedsurg.2011.01.012.","journal-title":"J Pediatr Surg"},{"key":"1101_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1525-1470.2011.01547.x","volume":"29","author":"E Hong","year":"2012","unstructured":"Hong E, Fischer G. Propranolol for recalcitrant ulcerated hemangioma of infancy. Pediatr Dermatol. 2012;29:64\u20137. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01547.x.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR69","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jaad.2011.01.025","volume":"64","author":"DJ Hermans","year":"2011","unstructured":"Hermans DJ, van Beynum IM, Schultze Kool LJ, van de Kerkhof PC, Wijnen MH, van der Vleuten CJ. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol. 2011;64:833\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2011.01.025.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-02030-7","volume":"51","author":"M Pensabene","year":"2025","unstructured":"Pensabene M, Cambiaso C, Patti M, Sergio M, Serra G, Grasso F, et al. Complicated infantile hemangiomas in the palate: case report of a newborn patient and review of the literature. Ital J Pediatr. 2025;51:171. https:\/\/doi.org\/10.1186\/s13052-025-02030-7.","journal-title":"Ital J Pediatr"},{"key":"1101_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13669","volume":"62","author":"M Farshchian","year":"2021","unstructured":"Farshchian M, Potts GA. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma. Australas J Dermatol. 2021;62:e580\u20131. https:\/\/doi.org\/10.1111\/ajd.13669.","journal-title":"Australas J Dermatol"},{"key":"1101_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/pde.14933","volume":"39","author":"C Meyer-Mueller","year":"2022","unstructured":"Meyer-Mueller C, Nicholson C, Polcari I, Boull C, Maguiness S. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol. Pediatr Dermatol. 2022;39:255\u20139. https:\/\/doi.org\/10.1111\/pde.14933.","journal-title":"Pediatr Dermatol"},{"key":"1101_CR73","doi-asserted-by":"publisher","first-page":"F155","DOI":"10.1136\/fetalneonatal-2011-301317","volume":"97","author":"V Cante","year":"2012","unstructured":"Cante V, Pham-Ledard A, Imbert E, Ezzedine K, L\u00e9aut\u00e9-Labr\u00e8ze C. First report of topical timolol treatment in primarily ulcerated perineal haemangioma. Arch Dis Child Fetal Neonatal Ed. 2012;97:F155\u20136. https:\/\/doi.org\/10.1136\/fetalneonatal-2011-301317.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1101_CR74","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jaad.2015.10.021","volume":"74","author":"MD Boos","year":"2016","unstructured":"Boos MD, Castelo-Soccio L. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). J Am Acad Dermatol. 2016;74:567\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2015.10.021.","journal-title":"J Am Acad Dermatol"},{"key":"1101_CR75","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1097\/GOX.0000000000000605","volume":"4","author":"CS Chang","year":"2016","unstructured":"Chang CS, Kang GC. Efficacious healing of ulcerated infantile hemangiomas using topical timolol. Plast Reconstr Surg Glob Open. 2016;4:e621. https:\/\/doi.org\/10.1097\/GOX.0000000000000605.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"1101_CR76","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1111\/jdv.17057","volume":"35","author":"QY Chen","year":"2021","unstructured":"Chen QY, Chang L, Qiu YJ, Ying HR, Chang SJ, Zhang Y, et al. Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study. J Eur Acad Dermatol Venereol. 2021;35:e303\u20135. https:\/\/doi.org\/10.1111\/jdv.17057.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1101_CR77","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/archpedi.1991.02160090114036","volume":"145","author":"JG Morelli","year":"1991","unstructured":"Morelli JG, Tan OT, Weston WL. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am J Dis Child. 1991;145:1062\u20134. https:\/\/doi.org\/10.1001\/archpedi.1991.02160090114036.","journal-title":"Am J Dis Child"},{"key":"1101_CR78","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archpedi.1994.02170100102023","volume":"148","author":"JG Morelli","year":"1994","unstructured":"Morelli JG, Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc Med. 1994;148:1104\u20135. https:\/\/doi.org\/10.1001\/archpedi.1994.02170100102023.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1101_CR79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/adc.74.2.161","volume":"74","author":"M Lacour","year":"1996","unstructured":"Lacour M, Syed S, Linward J, Harper JI. Role of the pulsed dye laser in the management of ulcerated capillary haemangiomas. Arch Dis Child. 1996;74:161\u20133. https:\/\/doi.org\/10.1136\/adc.74.2.161.","journal-title":"Arch Dis Child"},{"key":"1101_CR80","first-page":"117","volume":"25","author":"L Di Maio","year":"2011","unstructured":"Di Maio L, Baldi A, Dimaio V, Barzi A. Use of flashlamp-pumped pulsed dye laser in the treatment of superficial vascular malformations and ulcerated hemangiomas. In Vivo. 2011;25:117\u201323.","journal-title":"In Vivo"},{"key":"1101_CR81","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3109\/09546634.2016.1164287","volume":"27","author":"Y Li","year":"2016","unstructured":"Li Y, Hu Y, Li H, Deng L. Successful treatment of ulcerated hemangiomas with a dual-wavelength 595- and 1064-nm laser system. J Dermatolog Treat. 2016;27:562\u20137. https:\/\/doi.org\/10.3109\/09546634.2016.1164287.","journal-title":"J Dermatolog Treat"},{"key":"1101_CR82","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archfaci.7.5.312","volume":"7","author":"RF Thomas","year":"2005","unstructured":"Thomas RF, Hornung RL, Manning SC, Perkins JA. Hemangiomas of infancy: treatment of ulceration in the head and neck. Arch Facial Plast Surg. 2005;7:312\u20135. https:\/\/doi.org\/10.1001\/archfaci.7.5.312.","journal-title":"Arch Facial Plast Surg"},{"key":"1101_CR83","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2310\/7750.2012.12037","volume":"17","author":"CC McCuaig","year":"2013","unstructured":"McCuaig CC, Cohen L, Powell J, Hatami A, Marcoux D, Maari C, et al. Therapy of ulcerated hemangiomas. J Cutan Med Surg. 2013;17:233\u201342. https:\/\/doi.org\/10.2310\/7750.2012.12037.","journal-title":"J Cutan Med Surg"},{"key":"1101_CR84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.anpedi.2015.04.007(inSpanish)","volume":"84","author":"M Rodr\u00edguez-Ruiz","year":"2016","unstructured":"Rodr\u00edguez-Ruiz M, Tellado MG, del Pozo LJ. Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma. An Pediatr (Barc). 2016;84:92\u20136. https:\/\/doi.org\/10.1016\/j.anpedi.2015.04.007(inSpanish).","journal-title":"An Pediatr (Barc)"},{"key":"1101_CR85","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamapediatrics.2021.4565","volume":"176","author":"E Pope","year":"2022","unstructured":"Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, et al. Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma: a randomized clinical trial. JAMA Pediatr. 2022;176:34\u201341. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4565.","journal-title":"JAMA Pediatr"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-026-01101-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:47:54Z","timestamp":1791460074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-026-01101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":85,"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s12519-026-01101-x","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients\u2019 guardians approved the publication of clinical images.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no generative AI or AI-assisted technologies were used in the preparation of this manuscript.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}